Oral manifestations of secondary hyperparathyroidism related to long-term hemodialysis therapy.
Patients on long-term hemodialysis therapy may develop secondary hyperparathyroidism with oral symptoms. As the life expectancy of the dialysis patient increases, the dentist is seeing these manifestations with increasing frequency. A review of the subject is presented along with a case illustrating dramatic roentgenographic changes in a patient who was placed on hemodialysis when the technique was in its infancy.
D000328:Adult; D002116:Calcitonin / Q000502:physiology; D002118:Calcium / Q000378:metabolism; D002128:Calcium Metabolism Disorders / Q000209:etiology*; D003649:Decalcification, Pathologic / Q000000981:diagnostic imaging / Q000209:etiology*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000150:complications / Q000209:etiology*; D007571:Jaw Diseases / Q000000981:diagnostic imaging / Q000209:etiology*; D007676:Kidney Failure, Chronic / Q000150:complications; D008134:Long-Term Care; D008297:Male; D010281:Parathyroid Hormone / Q000502:physiology; D011859:Radiography; D006435:Renal Dialysis / Q000009:adverse effects*; D014807:Vitamin D / Q000502:physiology
D010281:Parathyroid Hormone; D014807:Vitamin D; D002116:Calcitonin; D002118:Calcium